@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-KWR-KW107404 a mbo:MassSpectrum ;
    dcterms:creator "Erik Emke, Andrea Brunner, KWR" ;
    dcterms:date "2017-03-12"^^xsd:date ;
    dcterms:identifier "MSBNK-KWR-KW107404" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Copyright (C) 2017 KWR watercycle research institute under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Orbitrap Classic, Thermo Scientific" ;
            mbo:collision_energy "65 eV FT-MS" ;
            mbo:column_name "XBridge C18 3.5um, 2.1x150mm, Waters" ;
            mbo:flow_gradient "95/5 at 0 min, 0/100 at 40 min, 0/100 at 45 min, 95/5 at 47 min, 95/5 at 52 min" ;
            mbo:flow_rate "300 uL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-ITFT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "30000" ;
            mbo:retention_time "16.137 min" ;
            mbo:solvent "A water with 0.05% formic acid",
                "B acetonitrile with 0.05% formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Irbesartan" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 4.282325e+02 ;
            rdfs:seeAlso cas:138402-11-6,
                chemspider:3618,
                pubchem:CID3749 ;
            schema:inChI "InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)" ;
            schema:inChIKey inchikey:YOSHYTLCDANDAN-UHFFFAOYSA-N ;
            schema:molecularFormula "C25H28N6O" ;
            schema:name "Irbesartan" ;
            schema:smiles "CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5" ] ;
    mbo:has_peak [ mbo:intensity 2.84276e+05 ;
            mbo:mz 1.671543e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 7.64717e+04 ;
            mbo:mz 1.960762e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 1 ],
        [ mbo:intensity 3.987378e+05 ;
            mbo:mz 2.05076e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 1.629814e+06 ;
            mbo:mz 2.060839e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 25 ],
        [ mbo:intensity 6.530758e+07 ;
            mbo:mz 2.070916e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.121055e+05 ;
            mbo:mz 2.08095e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 1.307042e+05 ;
            mbo:mz 3.181593e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 8.93655e+04 ;
            mbo:mz 3.722201e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 1 ],
        [ mbo:intensity 6.242235e+06 ;
            mbo:mz 3.862226e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 95 ],
        [ mbo:intensity 1.565357e+07 ;
            mbo:mz 4.012334e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 239 ],
        [ mbo:intensity 2.718913e+05 ;
            mbo:mz 1.780652e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 1.563088e+05 ;
            mbo:mz 1.79073e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 1.494585e+06 ;
            mbo:mz 1.800807e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 23 ],
        [ mbo:intensity 7.89197e+04 ;
            mbo:mz 1.892218e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 1 ],
        [ mbo:intensity 2.806484e+05 ;
            mbo:mz 1.900652e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 1.217184e+05 ;
            mbo:mz 1.91073e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 1.315254e+05 ;
            mbo:mz 1.920679e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 2 ],
        [ mbo:intensity 1.011646e+07 ;
            mbo:mz 1.951492e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 155 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 4.2924e+02 ;
            mbo:precursor_mz 4.292397e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 18 ;
    mbo:pk_splash "splash10-0a4i-0190200000-8d4413edfc6ff7554007" ;
    rdfs:comment "INTERNAL_ID 1074" ;
    skos:definition "Irbesartan; LC-ESI-ITFT; MS2; CE: 65 eV; R=30000; [M+H]+" .

